Moreover, low RBM47 expression was significantly associated with poor overall and relapse free survival in TCGA COAD and five additional CRC patient cohorts (Fig. 3b–g), Decreased expression of RBM47 was also significantly associated with poor overall and relapse free survival in the TCGA pan-cancer dataset, which encompasses expression profiles of more than 8400 cancer patients from 30 different entities (Supplemental Fig. S3). The gene discussed is RBM47; the disease is colorectal carcinoma.